PSDV - pSivida Limited Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PSDV - pSivida Limited

PSDV 1.220

+14.0%

Mar 29 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Arthur Radley who wrote (324)	11/19/2010 5:32:51 PM
From: John McCarthy	Read Replies (1) of 421

Hi Arthur (2nd reply) pharout912 (JUST) posted this on yahoo ..... The deadline for an advisory committee has passed ( 6 weeks prior to prioirty review date). This is a key event because the FDA typically uses a panel if there is a significant question about an NDA. I ( my opinion) is that this is a seminal event and increases the chances of approval significantly. I will discuss more tomorrow about my logic. Going to put a few bottles of champagne away.. we are closer than you think. As far as the label goes please note that the FDA has a good model to work with in the Retisert (for uveitis) is the same drug in a similiar system....more over the weekend but great catch ..... messages.finance.yahoo.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next